α-Synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 7, 2000, Pages 585-591

  Yamazaki, Mineo ^a,b,c   Arai, Yasushi ^b   Baba, Minami ^d,e   Iwatsubo, Takeshi ^d,e   Mori, Osamu ^b   Katayama, Yasuo ^b   Oyanagi, Kiyomitsu ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c Hatsuishi Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Amygdala; Guam; Parkinsonism dementia complex; Tau; synuclein

Indexed keywords

ALPHA SYNUCLEIN; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BRAIN REGION; CELL INCLUSION; CLINICAL ARTICLE; DEMENTIA; FEMALE; GUAM; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW;

EID: 0033936784     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.7.585     Document Type: Review

References (36)

1. Ueda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-86
2. Iwai A, Masliah E, Yoshimoto M, et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995;14:467-75
3. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. α-synuclein in Lewy bodies. Nature 1997;388:839-40
4. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 1997;239:45-48
5. Baba M, Nakajo S, Tu PH, et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-84
6. Irrizary MC, Growdon W, Gomez-Isla T, et al. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 1998;57:334-37
7. Tu PH, Galvin JE, Baba M, et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 1998;44:415-22
8. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1998;249:180-82
9. Lippa CF, Fujiwara H, Mann DMA, et al. Lewy bodies contain altered α-Synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998;153:1365-70
10. Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ. Antibodies to α-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann Neurol 1999;45:353-57
11. Hirano A, Kurland LT, Krooth RS, Lessell S. Parkinsonism-dementia complex, an endemic disease on the island of Guam I. Clinical features. Brain 1961;84:642-61
12. Hirano A, Malamud N, Kurland LT. Parkinsonism-dementia complex, an endemic disease on the island of Guam II. Pathological features. Brain 1961;84:662-79
13. Oyanagi K, Makifuchi T, Ohtoh T, et al. Amyotrophic lateral sclerosis of Guam: The nature of the neuropathological findings. Acta Neuropathol 1994;88:405-12
14. Oyanagi K, Wada M. Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: An update. J Neurol (Suppl 2:11) 1999;246:19-27
15. Buee-Scherrer V, Buee L, Hof PR, et al. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins. Am J Pathol 1995;146:924-32
16. Oyanagi K, Makifuchi T, Ohtoh T, Chen KM, Gajdusek DC, Chase TN. Distinct pathological features of the gallyas-and tau-positive glia in the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. J Neuropathol Exp Neurol 1997;56:308-16
17. Chen KM, Chase TN. Parkinsonism-Dementia Complex. In: Vinken PJ, Bruyn GM, Klawans HI, eds. Handbook clinical neurology Vol. 49. Extrapyramidal disorders. Revised series. New York: Elsevier Science, 1986:167-83
18. Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nature Med 1998;4:1318-20
19. Nakajo S, Omata K, Aiuchi T, et al. Purification and characterization of a novel brain-specific 14-kDa protein. J Neurochem 1990;55:2031-38
20. Nakajo S, Tsukada K, Omata K, Nakamura Y, Nakaya K: A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. Eur J Biochem 1993;217:1057-63
21. Shibayama-Imazu T, Okahashi I, Omata K, et al. Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14). Brain Res 1993;622:17-25
22. Nakajo S, Tsukada K, Kameyama H, Furuyama Y, Nakaya K. Distribution of phosphoneuroprotein 14 (PNP 14) in vertebrates: Its levels as determined by enzyme immunoassay. Brain Res 1996;741: 180-84
23. Jakes R, Crowther RA, Lee VM, Trojanowski JQ, Iwatsubo T, Goedert M. Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein. Neurosci Lett 1999;269:13-16
24. Shin RW, Iwaki T, Kitamoto T, Tateishi J. Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab Invest 1991;64:693-702
25. Dickson DW, Ruan D, Crystal H, et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscopic immunocytochemistry of CA2-3 neuntes specific to DLBD. Neurology 1991;41: 1402-9
26. Hirano A. Parkinsonism-dementia complex. In: Abe M, Omae T, Kawai C, eds. Parkinson's disease and parkinson syndrome. Internal medicine MOOK. Tokyo: Kanahara Shuppan, 1984: 165-73
27. Schmidt ML, Martin JA, Lee VM-Y, Trojanowski JQ. Convergence of Lewy bodies and neuroribrillary tangles in amygdala neurons in Alzheimer's disease and Lewy body disorders. Acta Neuropathol 1996;91:475-81
28. Wakabayashi K, Hayashi S, Kakita A, et al. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 1998;96:445-52
29. Garruto RM, Gajdusek DC, Chen KM. Amyotrophic lateral sclerosis and parkinsonism-dementia among Filipino migrants to Guam. Ann Neurol 1981;10:341-50
30. Garruto RM, Yanagihara R, Gajdusek DC. Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology 1985;35:193-98
31. Shankar SK, Yanagihara R, Garruto RM, Grundke-Iqbal I, Kosik KS, Gajdusek DC. Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Ann Neurol 1989;25:146-51
32. Pérez-Tur J, Buée J, Morris HR, et al. Neurodegenerative diseases of Guam: Analysis of TAU. Neurology 1999;53:411-13
33. Eidelberg D, Sotrel A, Joachim C, et al. Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinico-pathological entity. Brain 1987;110:993-1013
34. Wakabayashi K, Fukushima T, Koide R, et al. Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and Lewy body pathology. Acta Neuropathol 2000;99:331-36
35. Popovitch ER, Wisniewski HM, Kaufman MA, Grundke-Iqbal I, Wen GY. Young adult-form of dementia with neurofibrillary changes and Lewy bodies. Acta Neuropathol 1987;74:97-104
36. Okeda R, Kanazawa A, Yamada M, et al. A 14-year-old patient with Ewing's sarcoma presenting at autopsy with multiple neuroribrillary tangles and Lewy bodies in addition to hemiatrophy of the central nervous system. Clin Neuropathol 1997;16:77-84